Evaluate the role of androgen ablation and the androgen receptor axis as a target for the treatment of castration resistant prostate cancer |
|
|
|
|
|
Understand the role of immunotherapy in the treatment of mCRPC |
|
|
|
|
|
Appreciate the role of docataxel and cabazitaxel in the treatment of mCRPC as well as be familiar with the side effects and toxicities |
|
|
|
|
|
Explain clinical data and available therapeutic options, including radioisotopes and other bone-targeted agents, for the management of bone metastases in patients with mCRPC |
|
|
|
|
|
Discuss ways to evaluate the optimal sequencing of novel hormonal agents, immunotherapy, radioisotopes and chemotherapy in the treatment of CRPC |
|
|
|
|
|
Discuss the importance of multidisciplinary treatment strategies in the care of patients with advanced CRPC |
|
|
|
|
|